
Phreesia Inc (PHR) Stock Forecast & Price Target
Phreesia Inc (PHR) Analyst Ratings
Bulls say
Phreesia Inc. reported strong financial performance in its latest quarter, with patient payment volumes increasing to $1.181 billion, marking a year-over-year growth of 9.2%. Revenue growth reached 15.9% year-over-year, fueled by a significant rise in payment processing fees, which soared 44.8%, and an increase in total revenue per AHSC of 7.9%. Additionally, the company's pro forma operating margins improved to 23.2%, reflecting enhanced operational efficiency, while free cash flow surged to $28.5 million, illustrating strong cash generation capabilities.
Bears say
Phreesia's recent financial performance exhibited weaker-than-expected growth, with the company ending 4Q26 with 4,658 provider clients, falling short of the anticipated 4,700, and displaying a decline in year-over-year organic revenue growth from 13% to 7%. Additionally, the revenue contribution from AccessOne continues to decline, highlighting a concerning trend as its top line shrank from $49.2 million in 2023 to projections of $34.6 million through 3Q25. This underperformance is reflected in the stock's steep decline of 67% over the trailing twelve months, contrasting sharply with a 17% increase in the broader Russell 3000 index, indicating significant investor concern regarding the company’s growth trajectory and financial outlook.
This aggregate rating is based on analysts' research of Phreesia Inc and is not a guaranteed prediction by Public.com or investment advice.
Phreesia Inc (PHR) Analyst Forecast & Price Prediction
Start investing in Phreesia Inc (PHR)
Order type
Buy in
Order amount
Est. shares
0 shares